Mario Airoldi

机构：Azienda Ospedaliera Citta' della Salute e della Scienza di Torino, Department of Medical Sciences, IRCCS Humanitas Research Hospital, University of Turin · ORCID：0000-0002-1202-9973

发表论文 285 篇 · 总被引 4980 次 · h-index 30

代表论文

• Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study (2025 · Journal of Clinical Oncology · 被引 45)
• Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab (2024 · Journal for ImmunoTherapy of Cancer · 被引 13)
• SGLT2 inhibition improves PI3Kα inhibitor–induced hyperglycemia: findings from preclinical animal models and from patients in the BYLieve and SOLAR-1 trials (2024 · Breast Cancer Research and Treatment · 被引 7)
• TEAM Study: Upfront Docetaxel Treatment in Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Real-World, Multicenter, Retrospective Analysis (2023 · Clinical Genitourinary Cancer · 被引 6)
• Treatment of bone metastases from solid tumors with bone-modifying agents: a web survey of Italian oncologists investigating patterns of practice drug prescription and prevention of side effects (2024 · Supportive Care in Cancer · 被引 5)
• The oligometastatic setting in HNSCC: A critical review by the Rete Oncologica Piemonte e Valle d′Aosta multidisciplinary team (2023 · Critical Reviews in Oncology/Hematology · 被引 5)